"Located in Annie Penn Hospital, the Cone Health Cancer Center at Annie Penn offers comprehensive, leading-edge services in the area of cancer care. We specialize in the treatment of multiple cancer types including breast cancer, prostate cancer, colon cancer, skin cancer and more."

During the past decade, Annie Penn Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 20 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Annie Penn Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 12 trials, followed by "SWOG Cancer Research Network" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored and "Radiation Therapy Oncology Group" with 4 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Annie Penn Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 34 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Annie Penn Cancer Center" are "Breast Cancer" (7 trials), "Lung Cancer" (5 trials), "Colorectal Cancer" (3 trials), "Prostate Cancer" (3 trials) and "Esophageal Cancer" (2 trials). Many other conditions were trialed in "Annie Penn Cancer Center" in a lesser frequency.

Most popular intervention types in "Annie Penn Cancer Center" are "Drug" (26 trials), "Biological" (13 trials), "Other" (11 trials), "Radiation" (5 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "bevacizumab" (6 trials), "placebo" (5 trials), "cetuximab" (3 trials), "cisplatin" (3 trials) and "cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Annie Penn Cancer Center" are 23 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Annie Penn Cancer Center". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Annie Penn Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Annie Penn Cancer Center, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".